Blood

Published by: American Society of Hematology  

People

  1. Shah
    Shah
  2. Giralt
    Giralt
  3. Landau
    Landau
  4. Scordo
    Scordo
  5. Hassoun
    Hassoun
  6. Hultcrantz
    Hultcrantz
  7. Lesokhin
    Lesokhin
  8. Mailankody
    Mailankody
  9. Korde
    Korde
  10. Shah
    Shah

Groups

  1. Department of Medicine (47)
  2. Hematologic Malignancies, Division of (47)
  3. Center for Hematologic Malignancies (46)
  4. Bone Marrow Transplant (44)
  5. Survivorship Research (44)
  6. Hematology-Oncology Fellows (42)
  7. CTCR Scholars (40)
  8. Hematologic Malignancies Research (38)
  9. Sloan Kettering Institute Postdocs (38)
  10. Myeloma (34)
Search Within
  1. "Oscar Lahoud"
Formats
  1. Meeting Abstract (46)
  2. Journal Article (1)
Groups
  1. Department of Medicine (47)
  2. Hematologic Malignancies, Division of (47)
  3. Center for Hematologic Malignancies (46)
  4. Bone Marrow Transplant (44)
  5. Survivorship Research (44)
  6. Hematology-Oncology Fellows (42)

More Groups

People
  1. Oscar Lahoud (47)
  2. Gunjan Shah (39)
  3. Sergio Giralt (38)
  4. Heather Landau (36)
  5. Michael Scordo (36)
  6. Hani Hassoun (34)

More People

Years
  1. 2024 (3)
  2. 2023 (16)
  3. 2022 (8)
  4. 2021 (2)
  5. 2020 (6)
  6. 2019 (7)

More Years

Publishers
  1. American Society of Hematology (47)

Results (47)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective feasibility trial of pharmacokinetic directed melphalan for lymphoma patients undergoing autologous hematopoietic cell transplantation
    Meeting Abstract

    Hughes, C. F. M.; Lin, A.; Bromberg, M.; Devlin, S. M.; Saldia, A.; Engstler, D. E.; Hanley, D. M.; Aremu, Y.; Donach, M.; Hoover, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Body mass index trajectory during triplet induction therapy: Clinical implications in newly diagnosed multiple myeloma
    Meeting Abstract

    Thirugnanasambandam, R. P.; Firestone, R. S.; Derkach, A.; Furberg, H.; Shekarkhand, T.; Rueda, C.; Maclachlan, K. H.; Hultcrantz, M.; Mailankody, S.; Patel, D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma
    Journal Article

    Firestone, R. S.; Socci, N. D.; Shekarkhand, T.; Zhu, M.; Qin, W. G.; Hultcrantz, M.; Mailankody, S.; Tan, C. R.; Korde, N.; Lesokhin, A. M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Longitudinal assessment of minimal residual disease (MRD) in the ATLAS randomized phase 3 trial of post-transplant treatment with carfilzomib, lenalidomide, and dexamethasone (KRd) versus lenalidomide (R) alone in patients with newly diagnosed multiple myeloma (NDMM)
    Meeting Abstract

    Kubicki, T.; Dytfeld, D.; Wrobel, T.; Jamroziak, K.; Robak, P.; Czyz, J.; Tyczynska, A.; Druzd-Sitek, A.; Giannopoulos, K.; Nowicki, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Artificial intelligence enabled ECG interpretation informs outcomes after autologous transplantation for multiple myeloma
    Meeting Abstract

    Shaffer, B. C.; Attia, I. Z.; Greason, G.; Chinapen, S.; Brown, S.; Chung, D.; Lahoud, O. B.; Lopez-Jimenez, F.; Schaffer, W.; Liu, J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Responses and outcomes after second-line therapy in transplant-eligible patients with DLBCL relapse over 1 year after first-line therapy
    Meeting Abstract

    Qualls, D. A.; Shah, G. L.; Shouval, R.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Daratumumab, bortezomib, lenalidomide, and dexamethasone (DVRd) and daratumumab, carfilzomib, lenalidomide and dexamethasone (DKRd) as induction therapy in newly diagnosed multiple myeloma
    Meeting Abstract

    Tan, C.; Maclachlan, K. H.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Patel, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • T-cell exhaustion signature predicts early relapse after autologous stem cell transplant for multiple myeloma: BMT CTN 0702 secondary immune analysis
    Meeting Abstract

    Mehanna, N.; Derkach, A.; Gasmi, B.; Anagnostou, T.; Landau, H.; Lahoud, O. B.; Scordo, M.; Shah, G. L.; Hassoun, H.; Maclachlan, K. H.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Comprehensive genomic characterization of response and resistance to daratumumab-based quadruplet induction in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Maclachlan, K. H.; Tan, C. R.; Shekarkhand, T.; Rueda, C.; Serrano, E.; Nemirovsky, D.; Derkach, A.; McPherson, A.; Diamond, B.; Ziccheddu, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The complex structural variant chromothripsis can be defined on targeted sequencing panels, allowing direct clinical translation in order to improve multiple myeloma prognostication
    Meeting Abstract

    Maclachlan, K. H.; Ziccheddu, B.; Tan, C.; Shekarkhand, T.; Rueda, C.; Serrano, E.; Diamond, B.; Hassoun, H.; Mailankody, S.; Shah, U. A.; more...
    Blood (2023)

    Fulltext@MSK | Save

    • Blood – authorized name for:

    Name ISSN / ISBN Publisher
    Blood 0006-4971 American Society of Hematology
    Blood 00064971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 00064971 Unknown
    Blood 0006-4971 American Society of Hematology
    Blood 15280020 American Society of Hematology
    Blood 0006-4971 W.B. Saunders Co.
    Blood 1528-0020 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 Elsevier Inc.
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 15280020 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 00064971 2025
    Blood 00064971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology and American Society of Clinical Oncology
    Blood 0006-4971 American Society of Hematology
    Blood 15280020 Unknown
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 W.B. Saunders Co.
    Blood 1528-0020 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 00064971 2023
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology and American Society of Clinical Oncology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 1528-0020 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 00064971 2024
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology
    Blood 0006-4971 American Society of Hematology